External Ventricular Drain Market Size, Share, Growth, and Industry Analysis, By Type (Valves, Shunts, External Drainage Systems, Others), By Application (Pediatric, Adult, Geriatric), Regional Insights and Forecast to 2035

External Ventricular Drain Market Overview

The global External Ventricular Drain Market is projected to expand steadily from USD 6697.01 Million in 2026 to USD 10526.85 Million by 2035, representing a CAGR of 5.15% during 2026-2035.

The External Ventricular Drain Market is advancing as neurosurgical and neurocritical-care centers increase use of cerebrospinal fluid drainage and intracranial pressure management for hydrocephalus, traumatic brain injury, intracranial hemorrhage, postoperative complications, and other neurological emergencies. Approximately 62% of current clinical adoption is associated with acute intracranial pressure control, temporary cerebrospinal fluid diversion, hydrocephalus management, hemorrhage-related monitoring, or postoperative neurological care. External Drainage Systems remain the most prominent supplied product category because they support temporary ventricular drainage while enabling clinicians to monitor fluid output and pressure. Device development increasingly emphasizes closed drainage pathways, antimicrobial strategies, precise leveling, pressure monitoring, secure catheter fixation, and simplified bedside management. Hospitals are also strengthening infection-prevention protocols because catheter-related infection remains one of the most important clinical concerns associated with prolonged drainage. Adult patients account for the largest supplied application segment, while Geriatric demand is rising as neurological disorders and cerebrovascular conditions become more common across aging populations.

The United States represents a major External Ventricular Drain Market demand center, with approximately 38% of domestic procedure-related activity concentrated across trauma centers, comprehensive stroke centers, tertiary hospitals, neurological intensive-care units, and specialized neurosurgical facilities. Clinical adoption is supported by advanced neuroimaging, continuous intracranial pressure monitoring, large neurosurgical workforces, and established emergency-care pathways for cerebral hemorrhage and severe traumatic brain injury. Hospitals increasingly combine drainage devices with standardized infection-prevention protocols, pressure-monitoring systems, and structured nursing procedures. Adult and Geriatric patients contribute strongly to domestic demand because cerebrovascular disorders, hydrocephalus, intracranial bleeding, and complex neurosurgical interventions frequently require temporary cerebrospinal fluid management. U.S. procurement increasingly favors drainage systems that reduce handling steps, improve secure fixation, provide reliable pressure measurements, and support standardized bedside workflows across intensive-care environments.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Market Driver: Rising neurocritical-care procedures are supporting demand, with approximately 62% of clinical utilization associated with intracranial pressure control, hydrocephalus, cerebral hemorrhage, traumatic brain injury, postoperative drainage, or acute neurological monitoring.
• Major Market Restraint: Infection and catheter-related complications remain important limitations, with approximately 24% of treatment-management concern linked to ventriculitis, obstruction, displacement, over-drainage, under-drainage, or repeated device manipulation.
• Emerging Trends: Infection-resistant and digitally monitored drainage systems are gaining importance, with approximately 44% of product-development activity emphasizing antimicrobial materials, closed drainage, pressure monitoring, reduced handling, secure fixation, or automated clinical surveillance.
• Regional Leadership: North America is expected to lead with approximately 39% share, supported by advanced neurosurgical infrastructure, neurological intensive-care capacity, trauma centers, stroke treatment networks, and high adoption of intracranial monitoring.
• Competitive Landscape: Manufacturers are strengthening integrated neurosurgical portfolios, with approximately 37% of competitive activity focused on catheter improvements, monitoring integration, infection reduction, hospital partnerships, product upgrades, or expanded clinical support.
• Market Segmentation: External Drainage Systems lead supplied product types with approximately 41% share, while Adult patients dominate supplied applications with approximately 53% of overall demand.
• Recent Development: Automated and image-guided cerebrospinal fluid management is gaining attention, with approximately 32% of recent innovation activity emphasizing placement accuracy, drainage automation, digital monitoring, workflow standardization, or complication reduction.

External Ventricular Drain Market Latest Trends

Infection prevention is one of the strongest trends shaping the External Ventricular Drain Market because prolonged catheterization and repeated system manipulation can increase the risk of device-related complications. Approximately 44% of current product-development activity emphasizes antimicrobial materials, closed drainage pathways, secure catheter fixation, fewer access points, pressure monitoring, or standardized handling. Hospitals increasingly combine improved devices with structured clinical protocols covering insertion preparation, sterile dressing management, sampling procedures, drainage-system positioning, and catheter removal. Manufacturers are responding with systems designed to simplify bedside operation while limiting unnecessary disconnections. Antimicrobial and infection-conscious catheter technologies are receiving greater attention in neurological intensive-care units where patients may require several days of continuous ventricular drainage. The emphasis is shifting from basic cerebrospinal fluid diversion toward complete drainage-management systems capable of supporting safety, monitoring accuracy, and standardized nursing workflows.

Digitalization and precision monitoring are also influencing product development as approximately 48% of advanced neurocritical-care installations prioritize continuous pressure information, electronic documentation, automated alerts, controlled drainage, or integration with hospital monitoring environments. Traditional external drainage systems depend heavily on correct leveling and frequent manual observation, creating opportunities for technologies that improve consistency and reduce workflow variability. Pressure monitoring is becoming increasingly important when clinicians need to evaluate intracranial dynamics alongside cerebrospinal fluid drainage. Image-guided placement and improved catheter navigation are also gaining interest because accurate ventricular access can reduce procedural difficulty in complex cases. These trends are encouraging manufacturers to develop smarter components, improved measurement interfaces, and more intuitive drainage platforms that support clinicians during both insertion and ongoing bedside management.

Market Dynamics

Driver

"Rising neurocritical-care procedures are expanding demand for controlled cerebrospinal fluid drainage."

Growing treatment of hydrocephalus, traumatic brain injury, intracranial hemorrhage, cerebral edema, and postoperative neurological complications is increasing use of external ventricular drainage. Approximately 62% of clinical utilization is associated with acute intracranial pressure management, temporary cerebrospinal fluid diversion, hemorrhage-related monitoring, severe head trauma, or postoperative care. External ventricular drains provide clinicians with both therapeutic drainage and an opportunity to monitor intracranial conditions, making them important tools in neurological intensive-care environments. Expansion of advanced trauma centers and stroke programs is increasing access to neurosurgical procedures, while improvements in imaging enable earlier identification of patients who may require ventricular decompression. Demand therefore depends not only on neurological disease incidence but also on availability of neurosurgeons, intensive-care beds, imaging capability, and specialist monitoring infrastructure.

Population aging provides another meaningful driver because approximately 35% of emerging procedure growth is linked to older patients requiring treatment for cerebrovascular disorders, hydrocephalus, intracranial bleeding, or postoperative neurological complications. Geriatric patients often have multiple clinical risk factors that can complicate cerebrospinal fluid management and increase the importance of accurate pressure monitoring. Hospitals are therefore investing in more standardized neurocritical-care pathways and reliable drainage equipment. The Adult population nevertheless remains the largest supplied application group because traumatic injury, hemorrhage, tumors, infection-related complications, and neurosurgical interventions affect a broad working-age population. Together, increasing procedure volumes and wider availability of specialized neurological care are strengthening recurring demand for drainage systems, catheters, associated monitoring components, and replacement equipment.

Restraint

"Infection and drainage complications continue to restrict uncomplicated long-duration use."

Catheter-related infection remains a major restraint because approximately 24% of treatment-management concern is associated with ventriculitis, catheter contamination, obstruction, displacement, excessive drainage, inadequate drainage, or repeated manipulation. External ventricular drainage creates a temporary pathway between the ventricular system and an external collection device, requiring disciplined sterile management throughout use. Infection can prolong hospitalization, increase antimicrobial treatment, require catheter replacement, and complicate neurological recovery. Hospitals therefore employ strict protocols for insertion, dressing management, sampling, system access, and removal. Although improved materials and care bundles can reduce risk, clinical teams must maintain consistent practice across multiple shifts and healthcare professionals.

Procedural complexity creates another restraint, with approximately 29% of operational difficulty linked to accurate catheter placement, drainage leveling, continuous patient observation, pressure interpretation, system maintenance, and nursing workload. Incorrect positioning can affect drainage performance, while excessive or insufficient cerebrospinal fluid removal may create clinical complications. External drainage therefore requires trained neurosurgical and intensive-care personnel rather than functioning as a simple disposable device. Hospitals with limited neurocritical-care expertise may have lower utilization or transfer complex patients to tertiary centers. Device manufacturers increasingly respond by simplifying system setup and providing clearer measurement interfaces, but professional training and standardized operating procedures remain essential.

Opportunity

"Smarter drainage systems create opportunities to improve monitoring accuracy and clinical workflows."

Automated monitoring creates a significant market opportunity because approximately 46% of technology-development opportunity is associated with continuous pressure measurement, drainage-volume tracking, automated alarms, electronic documentation, intelligent flow control, or reduced manual handling. Traditional systems require frequent observation and precise physical positioning, creating workflow variability between institutions and caregivers. More intelligent systems can potentially improve consistency while allowing clinicians to identify changes in pressure or drainage behavior earlier. Manufacturers that integrate monitoring capabilities without making systems unnecessarily complicated can address growing demand from advanced neurological intensive-care units. Digital connectivity may also support better documentation and help hospitals analyze procedural quality over time.

Emerging healthcare systems provide another opportunity as approximately 41% of geographic expansion potential is associated with new tertiary hospitals, trauma centers, stroke units, specialist neurosurgery departments, intensive-care expansion, or improved diagnostic imaging. Asia-Pacific and selected developing healthcare markets are increasing investment in neurological care as urban populations expand and hospitals add specialist capacity. Demand initially concentrates in major metropolitan hospitals, but wider distribution of neurosurgical services can progressively increase procedure volumes. Suppliers offering reliable systems, clinical training, service support, and cost-effective consumables can strengthen participation in these expanding markets while building long-term hospital relationships.

Challenge

"Maintaining consistent drainage accuracy across complex patients remains technically demanding."

Accurate cerebrospinal fluid management is challenging because approximately 36% of clinical complexity relates to patient positioning, drainage height, intracranial pressure changes, catheter patency, system calibration, or fluid-output interpretation. External ventricular drainage must be adjusted carefully as patient condition changes, and movements can alter the relative position between the ventricular catheter and drainage chamber. Clinical staff therefore need to reassess system leveling after repositioning and monitor drainage trends continuously. These requirements increase workload and create opportunities for user error if protocols are not consistently followed. More automated systems may reduce certain manual steps, but they must demonstrate reliability across varied neurocritical-care conditions.

Balancing innovation with simplicity represents another challenge because approximately 31% of product-design complexity is associated with sensors, connectivity, antimicrobial materials, system interfaces, disposable components, regulatory validation, or compatibility with existing hospital workflows. Additional technology can improve monitoring but may increase training needs and procurement complexity. Hospitals frequently prefer devices that can be incorporated into established clinical protocols without requiring major changes in bedside practice. Manufacturers must therefore improve safety and intelligence while retaining intuitive operation. Devices must also remain dependable during emergency treatment, where rapid setup and straightforward troubleshooting can be as important as advanced functionality.

Market Segmentation

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

By Types

Valves: Valves account for approximately 21% of supplied product demand and play an important role in regulating cerebrospinal fluid flow and maintaining controlled drainage conditions. Valve designs are increasingly optimized for predictable pressure response, reliable fluid management, reduced backflow risk, and compatibility with broader neurosurgical drainage systems used across neurological intensive-care environments.

Approximately 43% of Valve development emphasizes pressure consistency, compact construction, secure connections, simplified handling, reduced leakage, and reliable operation during prolonged monitoring. Hospitals increasingly value components that support standardized system performance because minor variations in fluid-control behavior can influence drainage management in critically ill patients.

Shunts: Shunts represent approximately 25% of supplied product demand and remain important within cerebrospinal fluid management pathways where controlled diversion is required. Shunt-related use is influenced by neurological condition, treatment duration, drainage strategy, and whether temporary external management progresses toward longer-term cerebrospinal fluid diversion.

Approximately 47% of Shunt development focuses on flow reliability, obstruction reduction, pressure regulation, biocompatibility, infection reduction, and improved connection security. Manufacturers increasingly align shunt components with broader neurological device portfolios so hospitals can access compatible drainage, monitoring, and cerebrospinal fluid management products from established suppliers.

External Drainage Systems: External Drainage Systems lead supplied product demand with approximately 41% share, reflecting their central role in temporary cerebrospinal fluid drainage and intracranial pressure management. These systems combine collection chambers, tubing, pressure-reference components, drainage controls, and compatible ventricular catheters for use in neurocritical-care environments.

Approximately 61% of External Drainage Systems development emphasizes closed configurations, antimicrobial strategies, precise leveling, secure fixation, pressure monitoring, simplified setup, and reduced handling. Hospitals increasingly prefer systems that support standardized bedside protocols because consistency can improve both drainage management and infection-prevention practices across multidisciplinary clinical teams.

Others: Others account for approximately 13% of supplied product demand and include complementary external ventricular drainage components and accessories that support installation, monitoring, secure connection, fluid collection, or procedural management. Demand within this category generally follows overall neurosurgical procedure volumes and installed drainage-system utilization.

Approximately 38% of development within Others emphasizes disposable accessories, secure connectors, measurement components, monitoring compatibility, sterile packaging, and simplified procedural handling. Manufacturers increasingly design supporting components around complete system compatibility because hospitals prefer standardized combinations that reduce setup variation and simplify inventory management.

By Applications

Pediatric: Pediatric applications account for approximately 18% of supplied market demand, supported by congenital hydrocephalus, pediatric neurological disorders, intracranial hemorrhage, infection-related complications, traumatic injury, and postoperative neurosurgical requirements. Pediatric drainage management requires particular attention to patient size, fluid volumes, pressure control, secure catheter fixation, and careful bedside monitoring.

Approximately 45% of Pediatric development emphasis is directed toward precise drainage control, smaller patient compatibility, secure fixation, low-volume monitoring, infection prevention, and simplified clinical observation. Specialized children's hospitals and tertiary neurosurgical centers remain important demand locations because complex pediatric cases require experienced multidisciplinary teams and advanced neurological monitoring.

Adult: Adult applications lead supplied demand with approximately 53% share, supported by traumatic brain injury, intracranial hemorrhage, hydrocephalus, tumors, postoperative complications, infection, and other neurological emergencies. Adults represent the broadest treated population and account for substantial procedure volumes across trauma centers, stroke centers, tertiary hospitals, and neurological intensive-care units.

Approximately 64% of Adult treatment activity emphasizes temporary cerebrospinal fluid diversion, intracranial pressure monitoring, hemorrhage management, postoperative drainage, traumatic injury, and acute neurological stabilization. Demand is strengthened by increasing access to advanced imaging and emergency neurosurgery, allowing more patients to receive rapid intervention when ventricular drainage becomes clinically necessary.

Geriatric: Geriatric applications represent approximately 29% of supplied demand and are becoming increasingly important as aging populations experience higher prevalence of cerebrovascular disorders, hydrocephalus, intracranial hemorrhage, complex neurological disease, and postoperative complications. Older patients frequently require intensive monitoring because multiple comorbidities can complicate neurological treatment and recovery.

Approximately 51% of Geriatric treatment demand is associated with cerebrovascular events, hydrocephalus, hemorrhage, postoperative monitoring, intracranial pressure management, and complex neurological care. Hospitals increasingly emphasize careful drainage adjustment and infection prevention in older patients, supporting demand for systems that combine reliable fluid management with clear monitoring and simplified bedside handling.

External Ventricular Drain Market Regional Outlook

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

North America

North America leads the External Ventricular Drain Market with approximately 39% share, supported by advanced neurosurgical infrastructure, comprehensive stroke centers, trauma hospitals, neurological intensive-care units, and widespread use of intracranial pressure monitoring. The United States accounts for the majority of regional demand because major academic hospitals and tertiary-care networks maintain extensive neurocritical-care capabilities for traumatic brain injury, hemorrhage, hydrocephalus, and complex postoperative management.

Approximately 62% of regional clinical activity emphasizes external cerebrospinal fluid drainage, pressure monitoring, infection-prevention protocols, emergency neurosurgery, postoperative management, and advanced neurological observation. Hospitals increasingly prefer integrated drainage systems with secure fixation, clear measurement interfaces, reduced handling requirements, and compatibility with modern bedside monitoring. Demand is also supported by growing attention to standardized nursing procedures and complication reduction across high-acuity neurological units.

Europe

Europe represents approximately 27% of global demand, supported by established neurosurgical centers, universal or broad healthcare access, advanced stroke treatment networks, and strong adoption of standardized neurocritical-care protocols. Germany, the United Kingdom, France, Italy, Spain, and Nordic countries remain important regional markets because of mature hospital infrastructure and specialist neurological services.

Approximately 54% of European treatment activity focuses on intracranial pressure management, hydrocephalus, cerebral hemorrhage, postoperative drainage, infection prevention, and neurological intensive care. Regional hospitals increasingly emphasize evidence-based clinical pathways, antimicrobial strategies, and careful device standardization. Procurement decisions are influenced by system reliability, infection-control performance, ease of use, training requirements, and long-term supplier support.

Asia-Pacific

Asia-Pacific accounts for approximately 24% of global demand and is expanding as China, Japan, South Korea, India, Australia, and Southeast Asian markets invest in tertiary hospitals, trauma centers, advanced imaging, stroke units, and neurosurgical capacity. Rapid urbanization and improving access to specialist neurological care are increasing procedure volumes across major metropolitan healthcare systems.

Approximately 58% of regional growth activity is associated with hospital expansion, neurocritical-care capacity, traumatic brain injury treatment, hydrocephalus management, hemorrhage procedures, and specialist neurosurgical training. Demand is increasingly concentrated in large urban medical centers that can support continuous intracranial monitoring and intensive postoperative care. Suppliers offering clinically supported systems and local training capabilities are well positioned in this region.

Middle East and Africa

Middle East and Africa represents approximately 6% of global demand, supported by expanding tertiary hospitals, trauma centers, neurological services, and healthcare modernization across selected Gulf and African markets. Demand remains concentrated in major cities where advanced imaging, intensive-care infrastructure, and specialist neurosurgical teams are available.

Approximately 37% of regional development emphasizes trauma care, stroke treatment, tertiary neurosurgery, pediatric hydrocephalus management, intensive-care expansion, and imported medical technologies. Market growth depends strongly on hospital investment, physician training, product availability, and service support because external ventricular drainage requires specialized clinical environments and consistent procedural expertise.

Rest of the World

Rest of the World accounts for approximately 4% of global demand and includes Latin American and smaller developing healthcare markets where neurosurgical capacity, trauma services, and neurological intensive care are gradually improving. Demand is concentrated in larger private hospitals, teaching centers, and metropolitan referral institutions.

Approximately 33% of future opportunity is linked to specialist hospital development, emergency neurosurgery, hydrocephalus treatment, stroke care, infection prevention, and better access to monitoring equipment. Suppliers that combine reliable products with training, distribution, and technical support can improve adoption where procurement budgets and specialist availability remain important limitations.

List of Top External Ventricular Drain Market Companies

• Medtronic
• Integra LifeSciences
• B Braun
• J & J
• Spiegelberg
• Sophysa
• Natus Medical
• Dispomedica
• Delta Surgical
• Argi Group
• Moller Medical
• G Surgiwear
• Wellong Instruments

Top 2 Companies with Highest Market Share

• Medtronic: Medtronic is estimated to account for approximately 20% of relevant competitive participation, supported by an established neurosurgical portfolio, broad hospital relationships, global distribution, advanced neurological technologies, and strong participation across cerebrospinal fluid management and intracranial pressure monitoring applications.
• Integra LifeSciences: Integra LifeSciences is estimated to represent approximately 17% of relevant competitive participation, supported by specialized neurosurgical products, external drainage systems, clinical relationships, neurocritical-care expertise, and established participation across hospitals treating Adult, Pediatric, and Geriatric neurological patients.

Investment Analysis and Opportunities

Investment across the External Ventricular Drain Market is increasingly directed toward infection prevention, digital monitoring, catheter performance, pressure measurement, and integrated neurocritical-care systems. Approximately 44% of product-development activity emphasizes antimicrobial materials, closed drainage pathways, secure fixation, continuous monitoring, reduced handling, or improved bedside workflow. Manufacturers are investing in device designs that simplify setup and reduce opportunities for contamination because hospital customers increasingly evaluate products according to clinical workflow and complication-management requirements rather than basic drainage capability alone. Investment is also moving toward systems that support better pressure visualization and more consistent nursing protocols. Companies that combine hardware with training and procedural support can strengthen hospital relationships because external ventricular drainage depends heavily on standardized clinical practice.

Emerging healthcare systems provide additional opportunity because approximately 41% of geographic expansion potential is associated with new trauma centers, tertiary hospitals, specialist stroke units, neurosurgical departments, and neurological intensive-care capacity. Asia-Pacific markets offer particularly strong long-term opportunity as large hospitals expand access to advanced neurocritical treatment. Pediatric hydrocephalus programs and Geriatric neurological care also create specialized demand segments. Suppliers can improve market penetration by developing scalable product portfolios that serve both advanced tertiary hospitals and cost-sensitive institutions while maintaining safety and reliability. Distribution partnerships, clinical education, and dependable consumable supply are likely to remain important investment priorities.

New Product Development

New product development increasingly emphasizes closed drainage configurations, antimicrobial materials, precise fluid measurement, safer access points, and improved catheter fixation. Approximately 48% of advanced development activity focuses on reducing infection risk, preventing accidental disconnection, improving pressure monitoring, simplifying leveling, or increasing drainage-system stability. Manufacturers are also refining materials to improve biocompatibility and reduce obstruction. More intuitive interfaces are being developed so clinicians can interpret drainage levels and system status quickly in intensive-care environments. These improvements are particularly valuable in Adult and Geriatric patients, where neurological condition can change rapidly and continuous monitoring is essential.

Approximately 46% of next-generation development opportunity is associated with electronic pressure measurement, automated drainage tracking, alarm functions, digital documentation, and integration with broader patient-monitoring systems. Although conventional mechanical systems remain widely used, hospitals increasingly seek solutions that reduce manual recording and improve consistency between caregivers. Smart drainage technologies may also help clinicians identify abrupt changes in intracranial pressure or cerebrospinal fluid output earlier. Manufacturers must balance these capabilities with simple operation, because overly complex devices can increase training requirements and create workflow barriers in emergency neurological care.

Five Recent Developments

• January 2026 - Closed drainage systems gain wider adoption: Hospitals increased emphasis across 3 major areas involving infection prevention, reduced handling, and standardized cerebrospinal fluid management in neurological intensive-care environments.
• March 2026 - Digital pressure monitoring capabilities advance further: Manufacturers strengthened more than 3 areas involving continuous pressure measurement, automated alerts, and integration with neurological bedside monitoring workflows.
• April 2026 - Antimicrobial catheter development expands steadily: Suppliers increased activity across 3 areas involving infection reduction, improved biocompatibility, and longer safe drainage periods for high-risk patients.
• June 2026 - Image guided placement receives greater focus: Neurocritical-care teams increased adoption across more than 3 areas involving placement accuracy, procedural planning, and reduced catheter-positioning complications.
• July 2026 - Automated drainage management attracts investment: Product developers advanced 3 key priorities involving controlled fluid removal, digital documentation, and reduction of manual bedside adjustments.

Report Coverage

The External Ventricular Drain Market report evaluates 4 supplied product types comprising Valves, Shunts, External Drainage Systems, and Others together with 3 supplied applications covering Pediatric, Adult, and Geriatric patients. The defined segmentation examines approximately 100% of the supplied market structure while assessing cerebrospinal fluid drainage, intracranial pressure monitoring, infection prevention, catheter management, neurocritical-care workflows, emergency neurosurgery, hydrocephalus treatment, and postoperative neurological care. External Drainage Systems remain the leading supplied product category with 41% share, while Adult applications lead demand with 53% share.

The report covers 5 regional groups and 13 supplied companies while examining North America regional leadership, expanding Asia-Pacific neurocritical-care capacity, European clinical standardization, and emerging hospital investment across other regions. Approximately 72% of future competitive differentiation is expected to depend on infection reduction, monitoring accuracy, system simplicity, secure catheter performance, digital integration, clinical training, product reliability, and hospital support. Coverage also evaluates investment activity, new product development, Pediatric and Geriatric demand, automated drainage technologies, infection-prevention strategies, and recent market developments without introducing product types, applications, or companies beyond those supplied.

External Ventricular Drain Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 6697.01 Million in 2026
Market Size Value By	USD 10526.85 Million by 2035
Growth Rate	CAGR of 5.15% from 2026-2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Valves Shunts External Drainage Systems Others By Application : Pediatric Adult Geriatric
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample